OpenAlex
PricingAboutJobs
Log inGet started
Work

Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation

HTML

Year: 2005
Type: article
Study design: Clinical Trial
Source: Transplant International
DOI: 10.1111/j.1432-2277.2004.00076.x
Authors: Frank Pietruck, Andreas Kribben, Truyen Ngo Van, Daniel Patschan, Stephan Herget-Rosenthal, Onno Janssen, Klaus Mann, Thomas Philipp, Oliver Witzke
Institution: Essen University Hospital
Language: English

Topic: Renal Transplantation Outcomes and Treatments
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Keywords: rosiglitazone, new-onset diabetes, kidney transplantation, insulin sensitizers, tacrolimus, cyclosporine, prednisone, fasting blood glucose, drug safety, drug interactions, edema
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2047250310
FWCI: 4.054
Cites: 18
Cited by: 54
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security